Kymera Therapeutics (KYMR) Earnings Date & Reports

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patientsâ€™ lives... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

KYMR is expected to report earnings to rise 1.31% to -89 cents per share on May 01

Kymera Therapeutics KYMR Stock Earnings Reports

Q1'25

Est.

$-0.89

Q4'24

Missed

by $0.11

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.10

Q1'24

Beat

by $0.02

The last earnings report on February 27 showed earnings per share of -87 cents, missing the estimate of -76 cents. With 717.13K shares outstanding, the current market capitalization sits at 1.71B.

View a ticker or compare two or three

Compare

KYMR